DVAX
Dynavax Technologies Corp
Price:  
11.55 
USD
Volume:  
2,241,821.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Relative Valuation

-77.9%
Upside

As of 2024-06-16, the Relative Valuation of Dynavax Technologies Corp (DVAX) is 2.55 USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.55 USD, the upside of Dynavax Technologies Corp based on Relative Valuation is -77.9%.

The range of the Relative Valuation is 2.09 - 3.19 USD.

Range Selected
Trailing P/E multiples 37.9x - 45.4x 42.6x
Forward P/E multiples 29.7x - 36.8x 30.0x
Fair Price 2.09 - 3.19 2.55
Upside -81.9% - -72.4% -77.9%
11.55 USD
Stock Price
2.55 USD
Fair Price

DVAX Relative Valuation - Historical P/E Data

Date P/E
2024-06-14 164.36
2024-06-13 170.91
2024-06-12 172.19
2024-06-11 172.04
2024-06-10 171.76
2024-06-07 171.62
2024-06-06 174.61
2024-06-05 172.19
2024-06-04 171.90
2024-06-03 175.32
2024-05-31 170.62
2024-05-30 168.20
2024-05-29 164.07
2024-05-28 163.65
2024-05-24 162.08
2024-05-23 168.63
2024-05-22 169.06
2024-05-21 163.08
2024-05-20 162.08
2024-05-17 158.10
2024-05-16 160.52
2024-05-15 157.10
2024-05-14 156.53
2024-05-13 156.96
2024-05-10 152.69
2024-05-09 156.68
2024-05-08 165.78
2024-05-07 167.35
2024-05-06 165.64
2024-05-03 167.06
2024-05-02 166.78
2024-05-01 166.21
2024-04-30 161.80
2024-04-29 161.37
2024-04-26 159.52
2024-04-25 158.95
2024-04-24 162.51
2024-04-23 167.35
2024-04-22 168.49
2024-04-19 167.92
2024-04-18 161.37
2024-04-17 162.65
2024-04-16 163.51
2024-04-15 166.35
2024-04-12 168.49
2024-04-11 170.91
2024-04-10 170.05
2024-04-09 171.05
2024-04-08 171.47
2024-04-05 171.47